Analgesics - Lithuania | Statista Market Forecast

In Lithuania, the revenue generated in the Analgesics market in 2024 amounts to US$68.22m.
It is projected that the market will experience an annual growth rate of 8.65% (CAGR 2024-2029).
When compared globally, the United States generates the highest revenue in the market, with US$7.24bn in 2024.
In terms of per person revenues, in Lithuania generates US$25.33 in 2024.
Lithuania's analgesics market is experiencing a shift towards natural and herbal remedies, driven by increasing consumer preference for alternative medicine.

Definition:
The Analgesics market comprises over-the-counter natural and synthetic non-opioid analgesics (only in approved low doses) like Paracetamol, Ibuprofen, Aspirin, Diclofenac and other pain-relieving preparations. Legislation on opioid analgesics differs from country to country. According to the respective state legislation, legal opioid analgesics are included. In Germany, Austria and Switzerland, for instance, opioid analgesics are only included if they are not limited by the narcotics law and do not require prescription. Analgesics are included in the form of pills, capsules, gels and ointments. Not included are prescription medicines (e.g. morphine), anesthetics and homeopathic remedies. Among the top-selling painkillers are Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol and ASS. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional information:
The Analgesics market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics market in Lithuania has been steadily growing over the past few years, driven by increasing customer preferences for over-the-counter pain relief medications.

Customer preferences: Lithuanian consumers have shown a strong preference for analgesics as a means to alleviate pain and discomfort. This can be attributed to several factors, including the increasing awareness and acceptance of self-medication, the convenience of purchasing over-the-counter medications, and the rising incidence of chronic conditions that require long-term pain management. Additionally, the aging population in Lithuania has contributed to the growing demand for analgesics, as older individuals are more likely to experience chronic pain and seek relief through medication.

Trends in the market: One notable trend in the Analgesics market in Lithuania is the growing popularity of non-steroidal anti-inflammatory drugs (NSAIDs). These medications, such as ibuprofen and naproxen, are widely used for their analgesic and anti-inflammatory properties. The increasing availability and affordability of NSAIDs have made them a preferred choice for many consumers in Lithuania. Furthermore, there has been a shift towards the use of topical analgesics, such as creams and gels, which offer localized pain relief and are considered safer alternatives to oral medications.

Local special circumstances: Lithuania has a well-developed healthcare system, which includes a strong network of pharmacies and healthcare professionals. This infrastructure has played a crucial role in promoting the availability and accessibility of analgesics to the general population. Moreover, the Lithuanian government has implemented regulations to ensure the safety and quality of over-the-counter medications, further boosting consumer confidence in the analgesics market.

Underlying macroeconomic factors: The growing Analgesics market in Lithuania can also be attributed to underlying macroeconomic factors. The country has experienced steady economic growth in recent years, leading to an increase in disposable income among the population. This has allowed consumers to allocate a larger portion of their budget towards healthcare expenses, including the purchase of analgesics. Additionally, the rising prevalence of chronic conditions, such as arthritis and back pain, has created a sustained demand for pain relief medications in the market.In conclusion, the Analgesics market in Lithuania is witnessing steady growth due to increasing customer preferences for over-the-counter pain relief medications. The popularity of NSAIDs and topical analgesics, coupled with a well-developed healthcare system and favorable macroeconomic conditions, have contributed to the expansion of the market. As the demand for analgesics continues to rise, it is expected that the market will further evolve to meet the evolving needs of Lithuanian consumers.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.